Lithium Controlled-Release and Extended-Release Tablets and Quinupristin and Dalfopristin
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Quinupristin and Dalfopristin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: dalfopristin / quinupristin
Brand name: Synercid
Synonyms: Dalfopristin and quinupristin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Quinupristin and dalfopristin Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-QuinZyme coenzyme Q-10
- Lithium Controlled-Release and Extended-Release Tablets-Quiphile
- Lithium Controlled-Release and Extended-Release Tablets-Quit Nicotine Gum - Mint
- Lithium Controlled-Release and Extended-Release Tablets-Qutenza
- Lithium Controlled-Release and Extended-Release Tablets-Qvar
- Quinupristin and Dalfopristin-Lithium ER
- Quinupristin and Dalfopristin-Lithium Oral Solution
- Quinupristin and Dalfopristin-Lithium Salts
- Quinupristin and Dalfopristin-Lithium Syrup and Oral Solution
- Quinupristin and Dalfopristin-Lithobid
- Quinupristin and Dalfopristin-Lithostat